Medicare Part D

New Website Reveals DIR Fee Problems
New Website Reveals DIR Fee ProblemsNASP takes aim at DIR fees.
Are Rebates Responsible for Higher Drug Costs?A new study shows how the Medicare donut hole could be costing patients.
DIR Fees: What NCPA Wants from Part DIn a letter to the CMS, DIR fees take precedence
New Report: PBMs Push Drug Costs
New Report: PBMs Push Drug CostsAre PBMs responsible for higher drug prices or is something else to blame?
5 Ways to Improve Medicare Part DNCPA’s recommendations for improving the “increasingly complicated Part D marketplace.”
Small Doses: Pharmacy News Featuring Opioids, Ketamine, and More
Small Doses: Pharmacy News Featuring Opioids, Ketamine, and MoreSmall Doses is news for pharmacists in a way that works for you.
Pharmacists to Descend on Washington
Pharmacists to Descend on WashingtonDIR fees and health-care reform will lead pharmacists’ legislative concerns.
Four ways Medicare Part D has affected costs for diabetic patientsUnderstand Medicare Part D’s design and its coverage gap to offer the most affordable prescription drug options for patients.
Drug costs chief concern of Medicare recipientsMedicare Part D recipients are most concerned about prescription drug costs—and their co-pay costs are the most important factor when choosing a pharmacy.
Medicare Part D patients not taking blood pressure meds correctlyExpert offers specific actions for managed care execs to take